Overview

Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19

Status:
Active, not recruiting

Trial end date:
2021-12-31

Target enrollment:

Participant gender:

Summary

This study will compare two drugs (hydroxychloroquine and azithromycin) to see if hydroxychloroquine is better than azithromycin in treating hospitalized patients with suspected or confirmed COVID-19.

Phase:

Phase 2

Details

Lead Sponsor:

Intermountain Health Care, Inc.

Collaborator:

University of Utah

Treatments:

Azithromycin
Hydroxychloroquine